Ana Monfort-Vengut (@anamonfven) 's Twitter Profile
Ana Monfort-Vengut

@anamonfven

PhD at the Cell Cycle & Cancer Biomarkers Lab 🧬🧫 G de Cárcer Group @IIBmCSICUAM #CRISPRscreens #Cancer #CellCycle

ID: 1201099323657863169

linkhttps://www.linkedin.com/in/anamonfortvengut/ calendar_today01-12-2019 11:22:58

3,3K Tweet

735 Followers

894 Following

Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

Today, February 4th #WorldCancerDay, we present the last paper from the CCCB lab, in the journal #DrugResistanceUpdates. A huge effort, completely from scratch, under the leadership of Ana Monfort-Vengut and #Natalia_Sanz. 🧵(1/11) pubmed.ncbi.nlm.nih.gov/39855050/

Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

We performed a CRISPR screen to find biomarkers for the drug rigosertib (RGS), a multi-target compound with multiple described mechanisms of action that has been the subject of much controversy in recent years,... (2/11) mdpi.com/1999-4923/15/4…

Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

... and identified the kinase #WNK1, whose inactivation promotes resistance to rigosertib by preventing its typical mitotic arrest induction. (3/11)

... and identified the kinase #WNK1, whose inactivation promotes resistance to rigosertib by preventing its typical mitotic arrest induction. (3/11)
Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

RGS resistance seems to be mediated by changes in microtubule (MT) dynamics that become less dynamic upon WNK1 inhibition, confirming that rigosertib's primary mechanism of action is by targeting MTs. (4/11)

RGS resistance seems to be mediated by changes in microtubule (MT) dynamics that become less dynamic upon WNK1 inhibition, confirming that rigosertib's primary mechanism of action is by targeting MTs. (4/11)
Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

Indeed, WNK1 inactivation also alters the response to other MT-related poisons, promoting resistance to MT-destabilizing drugs such as colchicine or nocodazole and increasing sensitivity to MT-stabilizing drugs such as paclitaxel. (5/11)

Indeed, WNK1 inactivation also alters the response to other MT-related poisons, promoting resistance to MT-destabilizing drugs such as colchicine or nocodazole and increasing sensitivity to MT-stabilizing drugs such as paclitaxel. (5/11)
Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

WNK1 is a master sensor of osmotic stress. Interestingly, a hypoosmotic stress leads to a more efficient response to MT-destabilizing drugs, while a hyperosmotic stress does the opposite. (6/11)

WNK1 is a master sensor of osmotic stress. Interestingly, a hypoosmotic stress leads to a more efficient response to MT-destabilizing drugs, while a hyperosmotic stress does the opposite. (6/11)
Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

Finally, by using the FRET sensor CRONOS, we observe that WNK1 inhibition leads to increased intracellular molecular crowding, explaining why MT dynamics are reduced. (7/11)

Finally, by using the FRET sensor CRONOS, we observe that WNK1 inhibition leads to increased intracellular molecular crowding, explaining why MT dynamics are reduced. (7/11)
Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

In summary, we define a new molecular mechanism for microtubule-related drugs resistance or sensitivity, based in osmotic stress changes, governed by the WNK1 kinase. (8/11)

In summary, we define a new molecular mechanism for microtubule-related drugs resistance or sensitivity, based in osmotic stress changes, governed by the WNK1 kinase. (8/11)
IIBM (@iibmcsicuam) 's Twitter Profile Photo

📢 Cultura Científica de la U. Autónoma de Madrid UCCUAM también publica la nota de prensa del grupo de Guillermo de Cárcer Guillermo de Cárcer 🔴Científicos del #IIBmCSICUAM describen un mecanismo molecular que modifica la eficacia de la quimioterapia 👏👏 uam.es/uam/investigac…

📢 Cultura Científica de la U. Autónoma de Madrid  <a href="/UCCUAM/">UCCUAM</a> también publica la nota de prensa del grupo de Guillermo de Cárcer <a href="/GdC_CCCB_lab/">Guillermo de Cárcer</a> 

🔴Científicos del #IIBmCSICUAM describen un mecanismo molecular que modifica la eficacia de la quimioterapia 👏👏

uam.es/uam/investigac…
IIBM (@iibmcsicuam) 's Twitter Profile Photo

📢 El #IIBmCSICUAM está en portada en las NOTICIAS publicadas por CSIC esta semana‼️‼️‼️ 🌟Estamos batiendo récords 🤩 ⤵️ ✅#11F destacadas nuestras propuestas ✅Artículo relevante de Guillermo de Cárcer ✅La empresa cofundada por Wolfgang Link recibe 9M de euros No os perdáis 🧵👇

Guillermo de Cárcer (@gdc_cccb_lab) 's Twitter Profile Photo

Un auténtico placer enseñar a los alumnos de 3ºESO del Colegio ZOLA Villafranca Colegios Zola Madrid por qué ocurre el cáncer, y mostrar alguno de los experimentos de mi lab en el IIBM. Esas caras de asombro y las preguntas desinhibidas son el mejor regalo! Gracias! 💙💙

Un auténtico placer enseñar a los alumnos de 3ºESO del Colegio ZOLA Villafranca <a href="/ColegiosZola/">Colegios Zola Madrid</a> por qué ocurre el cáncer, y mostrar alguno de los experimentos de mi lab en el <a href="/IIBmCSICUAM/">IIBM</a>. Esas caras de asombro y las preguntas desinhibidas son el mejor regalo! Gracias! 💙💙
IIBM (@iibmcsicuam) 's Twitter Profile Photo

🧑‍🎓Compromiso #IIBmCSICUAM con la divulgación científica en los Centros Educativos 🗣️Guillermo de Cárcer da una charla sobre cáncer a estudiantes de 3º de la ESO del Colegio Zola 👏

IIBM (@iibmcsicuam) 's Twitter Profile Photo

🔝 ¡Éxito en el primer Seminario Gabriella Morreale-JUNIOR ! 🎓👩‍🔬👨‍🔬 Gran afluencia de jóvenes investigadores pre/postdoc y el Salón de Actos casi lleno👏 Desde el #IIBmCSICUAM agradecemos a Ana Monfort su inspirador seminario “De PhD a MSL”. 🚀 #CienciaJoven #SeminarioJunior

🔝 ¡Éxito en el primer Seminario Gabriella Morreale-JUNIOR ! 🎓👩‍🔬👨‍🔬 

Gran afluencia de jóvenes investigadores pre/postdoc y el Salón de Actos casi lleno👏

Desde el #IIBmCSICUAM agradecemos a Ana Monfort su inspirador seminario “De PhD a MSL”. 🚀 #CienciaJoven #SeminarioJunior